For laboratory research use only. Not for human or veterinary use. This is educational reference information, not medical advice.
Research Database / Peptides / AOD9604
AOD9604 · AOD9604 (Tyr-hGH 177-191 fragment analog)

AOD9604

Metabolics
Overview Research Publications Laboratory FAQ References
Overview
Scientific nameAOD9604 (Tyr-hGH 177-191 fragment analog)
SynonymsAOD-9604
AbbreviationAOD9604
CAS Number221231-10-3
Molecular formulaC78H123N23O23S2
Molecular weight1815.1 g/mol (average)
Sequence (one-letter)YLRIVQCRSVEGSCGF
Length16 residues
PubChem CID71300630
2D / 3D structure
2D chemical structure of AOD9604

Interactive sequence

Select a residue to see its amino acid.
Research Summary

Mechanisms under investigation

The following are areas of ongoing preclinical investigation. They describe hypotheses and observations reported in the literature, not established clinical effects.

Evidence tiers below reflect how much has been studied in each model type. Counts describe research volume — they do not indicate proven efficacy, safety, or clinical consensus.

Evidence base (transparent counts)

Cellular studies 1 publication
Animal studies 3 publications
Human observational reports 0 publications
Controlled human trials 0 publications
Review articles 1 publication
Publication Library

Selected literature

Filter by study model. Each record is classified for the evidence base above.

2015
Preclinical study evaluating intra-articular AOD9604, alone or combined with hyaluronic acid, in a rabbit model of osteoarthritis.Animal · rabbit · PubMed (26275694)
2015
Analytical study characterizing in vitro metabolism of AOD9604 and methods for its detection in biological matrices.Cellular · PubMed (25208511)
2004
Review article summarizing the development status and reported metabolic pharmacology of AOD-9604, a C-terminal fragment analogue of human growth hormone.Review · PubMed (15134286)
2001
Preclinical study comparing chronic administration of human growth hormone and AOD9604 on lipid metabolism endpoints in obese and beta3-adrenergic-receptor knockout mice.Animal · mouse · PubMed (11713213)
2001
Preclinical study reporting fat oxidation and body weight changes in obese mice after chronic treatment with human growth hormone or its modified C-terminal fragment (AOD9604).Animal · mouse · PubMed (11673763)

Each record maps to a structured evidence row with study model, species, and support level.

Laboratory Information

Handling and reference

Molecular weight calculator

Average-mass estimate from a one-letter sequence.

Reconstitution calculator

Laboratory concentration only. Not dosing guidance.

Frequently Asked Questions
What is AOD9604?
AOD9604 is a research compound; the identity and structure data shown here are compiled from public chemical databases (primarily PubChem). For laboratory research use only.
What research models has it been studied in?
The literature indexed here is predominantly cellular (in vitro) and animal studies. See the evidence base and publication library above for the transparent counts by study model.
Is there controlled human clinical trial evidence?
Controlled human clinical trials are counted separately in the evidence base above. Cellular and animal findings do not establish human clinical effects.
How is it stored and handled in a laboratory?
Refer to the laboratory information section above.
Is this intended for human use?
No. All information and materials are for laboratory research use only — not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.
Documentation

Research material & documentation

This profile is an educational reference. Lot-level laboratory documentation for materials supplied by Peptide Titans is published openly.

AOD9604 research material →  ·  Lot-specific Certificates of Analysis →  ·  How lots are tested →

References and Citation

Evidence records

  1. Preclinical study evaluating intra-articular AOD9604, alone or combined with hyaluronic acid, in a rabbit model of osteoarthritis. (2015) — in vivo — PubMed.
  2. Analytical study characterizing in vitro metabolism of AOD9604 and methods for its detection in biological matrices. (2015) — in vitro — PubMed.
  3. Review article summarizing the development status and reported metabolic pharmacology of AOD-9604, a C-terminal fragment analogue of human growth hormone. (2004) — review — PubMed.
  4. Preclinical study comparing chronic administration of human growth hormone and AOD9604 on lipid metabolism endpoints in obese and beta3-adrenergic-receptor knockout mice. (2001) — in vivo — PubMed.
  5. Preclinical study reporting fat oxidation and body weight changes in obese mice after chronic treatment with human growth hormone or its modified C-terminal fragment (AOD9604). (2001) — in vivo — PubMed.

Every record carries a study model, species, support level and review status in the evidence table.

Citation generator

Loading citation...

Explore the full research database

Browse peptide profiles, publications, and laboratory references — all research-only.

For laboratory research use only. Not for human or veterinary use. Educational reference information — not medical advice.